-transparent.png){kind=logo}
The enzyme-linked immunosorbent assay (ELISA) was employed in the study of red blood cells from patients with autoimmune hemolytic anemia. The ELISA was more sensitive and correlated with severity of hemolysis better than the direct antiglobulin test (DAT). It was helpful in diagnosing and following the clinical course in these patients. This was particularly true in the DAT-negative group, since the ELISA can detect smaller increases in red blood cell IgG than are required for a positive DAT.
Related Publications
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
January 2003,
Immunohematology,
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
January 1991,
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
January 2005,
Methods in molecular biology (Clifton, N.J.),
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
November 2003,
Current opinion in hematology,
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
September 1986,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
December 1982,
Fertility and sterility,
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
January 1983,
Transfusion,
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
November 2015,
Archives of pathology & laboratory medicine,
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
January 1981,
American journal of veterinary research,
D Bodensteiner, and
P Brown, and
B Skikne, and
F Plapp
January 1986,
Journal of clinical microbiology,
